Public Policies Protect Healthcare Worker Safety During COVID-19
One of the highest health policy priorities for the nursing community during the COVID-19 coronavirus pandemic is to ensure the safety of healthcare workers, particularly regarding the availability of personal protective equipment (PPE).
FDA Approves Luspatercept-Aamt for Anemia in Adults With MDS
On April 3, 2020, the U.S. Food and Drug Administration (FDA) approved luspatercept-aamt (Reblozyl®) for the treatment of anemia failing an erythropoiesis-stimulating agent and requiring two or more red blood cell (RBC) units over eight weeks in adult patients with very low- to intermediate-risk myelodysplastic syndromes with ring sideroblasts (MDS-RS) or with myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T).
Prevent a Global Nursing Shortage by Investing in Nursing’s Future, WHO Says
The world needs to invest in nursing education, jobs, and leadership if it intends to prevent the projected global shortage of nurses by 2030, the World Health Organization (WHO) said on April 6, 2020, in its State of the World’s Nursing 2020 report, a first-of-its kind look at nurses’ critical role in international health care.
- Read more about Prevent a Global Nursing Shortage by Investing in Nursing’s Future, WHO Says
- Add new comment
WHO Director-General Encourages Global Collaboration to ‘Flatten the Curve’
As the COVID-19 coronavirus pandemic continues to circle the globe, nations look to a strong source that can help coordinate information and provide insight for all people. Under the leadership of the director-general, the World Health Organization (WHO) has been that trustworthy entity. Tracking, reporting, and coordinating COVID-19’s many aspects, WHO is a hub that allows public health officials worldwide to receive information in real time.
- Read more about WHO Director-General Encourages Global Collaboration to ‘Flatten the Curve’
- Add new comment
Prevent, Recognize, and Manage Sepsis in Patients With Cancer
Because of weakened immune systems and prolonged treatment courses, patients with cancer have a higher chance of developing sepsis. Once acquired, sepsis puts patients at risk for hospitalization and increased morbidity and mortality. Prevention and prompt management are essential to improve outcomes.
Geographic Disparities Affect Clinical Trials Participation for Minorities
Clinical trials are a vital part of moving cancer care into the future. Enrollment and participation provide patients with cutting-edge treatments and build the knowledge base for clinicians to offer the best possible care available. Patients who enroll in clinical trials receive a high quality of care, increased surveillance, and a greater adherence to treatment protocols because of the nature of scientific study. However, Latino and African American participation in clinical trials is low compared to their representation in the U.S. population.
- Read more about Geographic Disparities Affect Clinical Trials Participation for Minorities
- Add new comment
CMS Grants Waivers to Providers During COVID-19 Public Health Emergency
In emergencies such as the COVID-19 coronavirus pandemic, government health agencies have the authority to grant waivers for various federal health programs. Starting on March 23, 2020, the Centers for Medicare and Medicaid Services (CMS) waived certain requirements and protocols for providers and beneficiaries.
- Read more about CMS Grants Waivers to Providers During COVID-19 Public Health Emergency
- Add new comment
Democrats Draft Fourth COVID-Response Bill; Trump Extends Social Distancing; Some Legislation Perpetuates Nursing Shortage
On March 30, 2020, Democrats in the U.S. House of Representatives began drafting a fourth COVID-19 coronavirus relief package to include substantial infrastructure investments, said Speaker Nancy Pelosi. Pelosi said the legislation could be ready for a vote by late April.
- Read more about Democrats Draft Fourth COVID-Response Bill; Trump Extends Social Distancing; Some Legislation Perpetuates Nursing Shortage
- Add new comment
State Governors Lead U.S. Response to COVID-19
Although the United States federal government is coordinating the nation’s public health campaign against the COVID-19 coronavirus pandemic, the states—and the governors in particular—are coordinating across the country and party lines to implement containment plans using all the public and private tools at their disposal.
FDA Provides COVID-19 Guidelines for Patients With Cancer and Healthcare Providers
As the United States combats the COVID-19 coronavirus pandemic, federal agencies like the U.S. Food and Drug Administration’s (FDA’s) Oncology Center of Excellence (OCE) are reassuring specific populations, such as those in the cancer community, that the agency is still patient-centered in its mission.